---
title: "Tianmu Pharmaceutical: The 2023 internal control audit report with an emphasis on matters section has no reservations, and the issues involved have been resolved"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233880260.md"
description: "Tianmu Pharmaceutical announced that Unitas Zhengqing Certified Public Accountants conducted an audit of the effectiveness of the company's internal control over the financial report for the year 2023 and issued an internal control audit report with an unqualified opinion with an emphasis of matter paragraph. The company's board of directors now provides a special explanation regarding the matters mentioned in the emphasis of matter paragraph of the 2023 internal control audit report, indicating that the impacts have been eliminated. The company has completed the rectification of the matters involved in the internal control audit report with an unqualified opinion for the year 2023"
datetime: "2025-03-31T11:56:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233880260.md)
  - [en](https://longbridge.com/en/news/233880260.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233880260.md)
generator: "portal-rs"
---

# Tianmu Pharmaceutical: The 2023 internal control audit report with an emphasis on matters section has no reservations, and the issues involved have been resolved

Tianmu Pharmaceutical announced that Unita Zhenqing Certified Public Accountants conducted an audit of the effectiveness of the company's internal controls over the financial report for the year 2023 and issued an internal control audit report with an unqualified opinion with an emphasis of matter paragraph. The company's board of directors now provides a special explanation regarding the matters mentioned in the emphasis of matter paragraph of the 2023 internal control audit report, indicating that the impacts have been eliminated. The company has completed the rectification of the matters involved in the internal control audit report with an unqualified opinion for the year 2023

### Related Stocks

- [600671.CN](https://longbridge.com/en/quote/600671.CN.md)

## Related News & Research

- [St Joseph subsidiary Fastbase AI prepares beta launch of global business search platform](https://longbridge.com/en/news/296792561.md)
- [Acosta Verde launches shareholder preemptive rights offering at MXN 171.85 per share](https://longbridge.com/en/news/296830566.md)
- [Trump's trade war with Canada could lead the U.S. back to quantitative easing](https://longbridge.com/en/news/296820985.md)
- [SCIB Records RM6.31 Million Q2 FY2026 PAT as Strategic Transformation Advances](https://longbridge.com/en/news/296850603.md)
- [CANSINOBIO  Tetanus Vaccine New Drug Application Approved](https://longbridge.com/en/news/296498620.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**